Literature DB >> 20206548

Global graying, colorectal cancer and liver metastasis: new implications for surgical management.

Daniel A Anaya1, Natasha S Becker, Neena S Abraham.   

Abstract

Aging of the population - global graying - is occurring rapidly, with significant effects on epidemiology, treatment and outcomes for cancer patients. In colorectal cancer, outcomes for the elderly are worse than those for younger patients, partially driven by treatment disparities between the two groups. Nonetheless, standard-of-care treatment for the elderly results in equivalent long-term outcomes to those observed in the younger population; and available data support the use of aggressive surgery and adjuvant therapies in well-selected patients. Data evaluating epidemiology, treatment patterns and outcomes in elderly patients with colorectal cancer liver metastasis are lacking. Liver resection offers the only curative approach, but it is rarely offered to older adults. Current data support the use of hepatectomy for well-selected elderly colorectal cancer patients with liver metastasis; however, this and other evolving therapies need to be assessed in the elderly to better define their role, indications, safety and outcomes. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20206548     DOI: 10.1016/j.critrevonc.2010.02.003

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  14 in total

Review 1.  Liver metastases.

Authors:  Diamantis I Tsilimigras; Pnina Brodt; Pierre-Alain Clavien; Ruth J Muschel; Michael I D'Angelica; Itaru Endo; Rowan W Parks; Majella Doyle; Eduardo de Santibañes; Timothy M Pawlik
Journal:  Nat Rev Dis Primers       Date:  2021-04-15       Impact factor: 52.329

Review 2.  Surgical management of colorectal liver metastases: a European perspective.

Authors:  Declan Fj Dunne; Robert P Jones; Hassan Z Malik; Stephen W Fenwick; Graeme J Poston
Journal:  Hepat Oncol       Date:  2013-12-20

3.  The effects of age, education, and treatment on physical, sexual and body concern symptoms among multimorbid, colorectal cancer survivors.

Authors:  Aanand D Naik; Natalie Uy; Daniel A Anaya; Jennifer Moye
Journal:  J Geriatr Oncol       Date:  2015-04-24       Impact factor: 3.599

4.  Association of a Frailty Screening Initiative With Postoperative Survival at 30, 180, and 365 Days.

Authors:  Daniel E Hall; Shipra Arya; Kendra K Schmid; Mark A Carlson; Pierre Lavedan; Travis L Bailey; Georgia Purviance; Tammy Bockman; Thomas G Lynch; Jason M Johanning
Journal:  JAMA Surg       Date:  2017-03-01       Impact factor: 14.766

5.  TNF-α suppression by glutathione preconditioning attenuates hepatic ischemia reperfusion injury in young and aged rats.

Authors:  Arumugam Suyavaran; Chitteti Ramamurthy; Ramachandran Mareeswaran; Ariraman Subastri; Polaki Lokeswara Rao; Chinnasamy Thirunavukkarasu
Journal:  Inflamm Res       Date:  2014-11-25       Impact factor: 4.575

Review 6.  Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Authors:  Jayshree Mishra; Joseph Drummond; Sohel H Quazi; Satya Sridhar Karanki; J J Shaw; Ben Chen; Narendra Kumar
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-23       Impact factor: 6.312

7.  Impact of liver-directed therapy in colorectal cancer liver metastases.

Authors:  Gabriela M Vargas; Abhishek D Parmar; Kristin M Sheffield; Nina P Tamirisa; Kimberly M Brown; Taylor S Riall
Journal:  J Surg Res       Date:  2014-06-04       Impact factor: 2.192

8.  Changes of T cells and cytokines TGF-β1 and IL-10 in mice during liver metastasis of colon carcinoma: implications for liver anti-tumor immunity.

Authors:  Xiaoming Huang; Yifeng Zou; Lei Lian; Xiaojian Wu; Xiaosheng He; Xiaowen He; Xianrui Wu; Yan Huang; Ping Lan
Journal:  J Gastrointest Surg       Date:  2013-05-14       Impact factor: 3.452

9.  Postoperative mortality and need for transitional care following liver resection for metastatic disease in elderly patients: a population-level analysis of 4026 patients.

Authors:  Sonia T Orcutt; Avo Artinyan; Linda T Li; Eric J Silberfein; David H Berger; Daniel Albo; Daniel A Anaya
Journal:  HPB (Oxford)       Date:  2012-09-28       Impact factor: 3.647

10.  Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer.

Authors:  Jingtao Wang; Feifei Cui; Xiao Wang; Yingming Xue; Jian Chen; Yang Yu; Huijun Lu; Meng Zhang; Huamei Tang; Zhihai Peng
Journal:  J Exp Clin Cancer Res       Date:  2015-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.